Object. The authors provide a detailed review of the surgical management of trigeminal schwannomas (TSs) and also discuss the best surgical approach based on the surgical anatomy and tumor extension.
S chwannomaS originating from cranial nerves are usually benign, isolated, and slow growing. They may occur in multiple sites when associated with NF2. Schwannomas arising from the trigeminal nerves are the second most common type of intracranial schwan nomas, representing 0.8-8% of these tumors. 5, 29, 38, 46 Tri geminal schwannomas tend to occur in middleaged pa tients; the highest incidences are between the ages of 38 and 40 years, and are more common in women. 23, 24, 45 Pa tients with TS frequently complain of trigeminal nerverelated symptoms, but they may also be asymptomatic. In a recent review of the literature, Samii et al. 41 reported trigeminal nerve symptoms in 51% of patients, followed by headaches (16%) and diplopia (11%). The treatment of choice remains resection. In 1918, Frazier 14 reported the first surgical removal of a TS. Prior to the advent of CT and MR imaging, the diagnosis of TS was difficult.
Indeed, high death rates had been associated with sur gical treatment prior to the late 1950s. 43 Since then, in addition to a large series of 111 patients, 24 several small series 7, 9, 27, 29, 41 have demonstrated positive results and low mortality and morbidity rates associated with complete resection. Different surgical approaches may be used de pending on the location and extension of the lesion.
Surgical Anatomy
Recent advances in understanding the microsurgical anatomy of skull base structures are hallmarks of mod ern neurosurgery. Findings reported in the literature have proven, specifically in trigeminal nerve schwannomas, that a precise 3D knowledge of the dural, venous, and nerve anatomy of the cavernous sinus acquired through dissections of laboratory specimens is mandatory. 9, 10, 42 Moreover, clinical surgical experience in resecting tu mors within such a complex region is necessary to re move the maximum amount of the tumor safely. 12, 13 The trigeminal nerve emerges from the ventrolat eral surface of the pons and runs anteriorly ~ 1-2 cm 6 Surgical management of trigeminal schwannomas through the cerebellopontine cistern to reach the petrous apex. Vascular structures such as the petrosal vein and the superior cerebellar artery lie close to the trigeminal nerve. Over the petrous apex, ~ 7 mm of distance from the medial lip of the internal acoustic meatus, 26 the Gas serian ganglion is enveloped by a dural deflection forming the Meckel cave, laterally to the cavernous sinus and the carotid artery. As it leaves the Meckel cave, the trigemi nal nerve is divided into 3 branches: the ophthalmic (V1), maxillary (V2), and mandibular (V3) branches. These 3 nerves run under the middle fossa dura mater and leave the temporal bone through the lateral wall of the cavern ous sinus (for V1), foramen rotundum (for V2), and fora men ovale (for V3).
The trigeminal nerve can also be surgically classified into 3 segments: cisternal, from the brainstem to the pe trous apex; intracranialextradural, from the Meckel cave to the foramina; and extracranial (V1, V2, and V3).
Functionally, the trigeminal nerve has 2 portions: the "pars compacta," which constitutes the triangular por tion and comprises the primary afferent fibers that are responsible for the special sensibility of the face; and the motor root, which carries the branchiomotor fibers to the muscles of mastication. The motor root runs practically separated from the "pars compacta" but together with the cranial portion of the nerve. At the level of the Meckel cave, it is oriented medially and leaves the skull together with the maxillary nerve.
The intracranialextradural portions of V2 and V3 are surgically identified using the foramen spinosum as an anatomical landmark, which is located at the sphenoid bone and contains the middle meningeal artery. The fo ramina ovale and rotundum are located ~ 2-5 mm super oanteriorly and 10-12 mm superomedially to the foramen spinosum, respectively.
Classification of Tumor Extension
Trigeminal schwannomas may originate from the root, the ganglion, or the peripheral branches of the trigeminal nerve. Jefferson 22 initially divided these tumors into 4 groups depending on their anatomical location: posterior fossa (root type), combined posterior fossa-middle fossa (dumbbell type), middle fossa (ganglion type), and pe ripheral (division type). Samii et al. 41 classified the tumor extension into 4 categories based on radiological findings: Type A, intracranial tumor predominantly in the middle fossa; Type B, intracranial tumor predominantly in the posterior fossa; Type C, intracranial dumbbellshaped tumor in the middle and posterior fossa; and Type D, ex tracranial tumor with intracranial extensions.
In our institution, we prefer to use the classifica tion of Samii et al. 41 , with the following modifications: Type A, predominantly an extracranial tumor with small extension in the middle fossa (Fig. 1A) ; Type B, an in tracranial tumor predominantly in the middle fossa with extracranial extension (Fig. 1B) ; Type C, a tumor in the middle fossa (Fig. 1C) ; Type D, a tumor in the posterior fossa (Fig. 1D) ; Type E, a tumor with middle and poste rior fossa extensions (Fig. 1E) ; and Type F, a tumor with extracranial, middle, and posterior fossa extensions (Fig.  1F) . In our opinion, these modifications are important to assure the best surgical approach for each type of lesion. In the experience of the senior author (R.R.), each sub group of this modified classification presents a different surgical challenge. Tumor types are ordered according to the level of difficulty as A, C, D, B, E, and F. The degree of difficulty in radical surgical removal depends on the particularities of each case, but according to this modi fied classification, Type A tumors have the lowest level of difficulty and Type F tumors, on the contrary, the high est.
Surgical Approaches
According to the aforementioned classification ( Table  1) , Type A tumors are resected via an extradural approach (transmaxillary approach) (Fig. 2) or TM associated with an extradural middle fossa approach if there is broad ex tension to the middle fossa. Type B lesions are removed through an intradural middle fossa approach; large ex tradural tumor extensions, however, may require a trans maxillary exposure (Fig. 3 ). Type C tumors are extirpated via a middle fossa approach, either intradurally (for large lesions) or extradurally (for small lesions) (Fig. 4) . Resec tion of Type D tumors is best achieved via the retrosig moid approach (Fig. 5) . Type E tumors are extirpated us ing a presigmoid approach or 2staged retrosigmoid and middle fossa approaches 4 ( Fig. 6 ). As stated before, Type F tumors are considered the most challenging lesions and may demand a combination of all previously described approaches ( Fig. 7) .
Transmaxillary Approach (Caldwell-Luc Procedure). This procedure is usually performed in association with the middle fossa approach to remove large TSs. In our series, it was used to remove a large schwannoma within the maxillary sinus with small extension to the middle fossa and the cavernous sinus. After induction of general anesthesia, the gingiva is infiltrated with lidocaine 1% with 1:100,000 epinephrine solution. A 3cm incision is made over the upper canine and the upper first premolar tooth. To improve the suturing, 1 cm of gingival tissue is left intact above the dentition. Soft tissue and periosteum are elevated from the anterior wall of the maxilla. The in fraorbital nerve is identified as it exits the infraorbital fo ramen (midpupillary line). The anterior wall of maxillary sinus is opened. The tumor is identified and microsurgi cal intracapsular debulking is performed. Total removal of the maxillary, middle fossa, and cavernous sinus por tions is accomplished with this approach. The incision is closed with 40 absorbable sutures.
Middle Fossa Approach. The patient is placed supine with the head fixed in a 3-pin device and rotated ~ 30° to the opposite side. A Cshaped skin incision over the pterium is performed. The temporalis muscle fascia is in cised to protect the frontal branch of the facial nerve, and the scalp-fascia flap is lifted anteriorly. The temporalis muscle is retracted inferiorly and posteriorly. A pterional craniotomy is performed and enlarged to the base of the temporal fossa by removing bone with a rongeur to obtain a flat viewing angle across the floor of the middle fossa. The dura mater is then dissected and elevated from the middle fossa, exposing the superior orbital fissure. The middle meningeal artery is coagulated and transected.
The second and third branches of the trigeminal nerve are identified. The foramen ovale and rotundum are ex posed using a drill. The dura mater is elevated from the lateral cavernous sinus wall, revealing the tumor extra durally and the branches of the trigeminal nerve. The tumor is debulked and its capsule is dissected from the intact branches of the trigeminal nerve, which allows rad ical removal of the lesion. Large tumors are approached intradurally by opening the sylvian fissure and exposing the optic nerve, the internal carotid artery, and the third cranial nerve. The lateral cavernous sinus wall is exposed via a temporopolar approach and the tumor is removed. The trigeminal fibers are preserved as much as possible. The petrous apex is drilled and the petroclinoidal liga ment is cut to expose the posterior fossa portion, allowing complete excision of the remaining tumor.
Retrosigmoid Approach. This approach is performed by placing the patient in the dorsal (mastoid) position with the head turned to the opposite side and the ipsilateral shoulder elevated. A linear incision is placed 4 cm behind the external auditory canal. The asterium is exposed to determine the junction of the tranverse and sigmoid si nuses. A craniotomy 4 cm in diameter is performed, with the superior and anterior margins bordering the trans verse and sigmoid sinuses, respectively. The dura mater is opened parallel to the sigmoid sinus; CSF is drained from the cerebellomedullary cistern; and CNs VIIXI are iden tified. The tumor is thereby exposed near the tentorium margin. After intracapsular tumor debulking, microsurgi cal radical removal is accomplished. A watertight dural closure is completed, and the bone flap is fixed in place. All opened mastoid cells are sealed with bone wax to help prevent CSF leaks.
Presigmoid Approach. The patient is placed in the dorsal (mastoid) position. A Cshaped skin incision from the middle fossa to the mastoid tip is performed. Two bur holes are placed anteriorly and 2 are placed posteriorly at the intersection of the transverse and sigmoid sinuses. The temporal and retromastoid dura mater is exposed through a craniotomy. Mastoidectomy with preservation of the labyrinth block and the facial nerve canal is the next surgical step. Parallel dural incisions to the middle fossa floor are made anteriorly to the sigmoid sinus. The superior petrosal sinus is then ligated and transected. At this point, the inferior temporal lobe and the lateral por tion of the cerebellum are slightly retracted so that the vein of Labbé is preserved. The tumor is identified and the seventh and eighth cranial nerves are usually dis placed inferiorly. The tumor within the cavernous sinus is removed after opening its lateral wall. After complete excision of the tumor, the dura maer is closed in a wa tertight fashion and the skull base is reconstructed with myofascial flaps.
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Methods
This series includes 17 patients who were surgically treated between 1987 and 2008 at our institution. Two pa tients received a diagnosis of NF2. One patient presented with a posterior communicating artery aneurysm on the same side as the TS. There were 2 Type A, 2 Type B, 5 Type C, 2 Type D, 4 Type E, and 2 Type F tumors ( Table  1 ). The cavernous sinus was involved in 13 cases. The sizes of the lesions were small (< 3 cm) in 2, medium (between 3 and 4 cm) in 5, large (> 4 cm) in 6, and giant (> 5 cm) in 4 cases.
The clinical symptoms in these patients included trigeminal hypesthesia (9 patients), facial pain (9 pa tients), headaches (6 patients), hearing impairment (3 pa tients), seizures (3 patients), diplopia (2 patients), ataxia (2 patients), and hemiparesis and increased ICP with papilledema (1 patient) ( Table 2 ). Prior to 1990, the extent of resection was confirmed by postoperative imaging. After 1990 all patients underwent pre and postoperative CT and MR imaging studies. In our series, postoperative imaging examinations were routinely performed 3 days after surgery. Recurrence was defined as a new lesion identified on routine MR imaging in a patient considered to have had total resection. Progression was related to tu mor growth in a patient considered to have had subtotal or partial resection, as demonstrated by immediate post operative MR imaging. Postoperatively, imaging exami nations are performed every 6 months for 2 years, then once a year for 5 years, and after that every 2 years. The mean followup duration for this series was 10.5 years (6 months-21 years), corresponding to 121.6 months (6-252 months), with an average of 0.8 patients per year.
Results
Total tumor excision was possible in 16 patients, whereas total removal was not achieved in 1 patient with NF2 due to adherences within the cavernous sinus. There were no surgeryrelated deaths (Table 3) . Seven patients developed postoperative anesthesia in at least one branch of the trigeminal nerve. Trigeminal motor function was preserved in 7 patients. Two individuals developed a CSF leak and were successfully treated by lumbar CSF drain age. Only 1 of the 9 patients who reported facial pain pre operatively remained symptomatic postoperatively. Two patients exhibited minimal facial palsy that resolved dur ing the followup period. The patient with preoperative hemiparesis showed progressive improvement after sur gery. There was 1 recurrence in a patient with NF2, and that occurred 5 years after a radical removal of a Type C tumor. The recurrent tumor was removed, with an un eventful postoperative outcome.
Discussion
Although TSs are the second most common intrac ranial schwannoma, there is no typical clinical syndrome caused by TSs. Nevertheless, the most frequently noted symptoms related to trigeminal nerve dysfunction mani fest as decreased sensation over the involved trigeminal nerve branch distribution, the whole face, and eventually corneal reflex alteration. 29, 41 Instead of pain, sensory dis turbance is mostly described as numbness and paresthe sia. Some authors reported that ~ 10% of patients will not present with trigeminal dysfunction as an initial symp tom. 27, 38 When present, however, facial pain can affect one or more trigeminal branches. Intensity may vary from light to lancinating pain. It may occur in paroxysms, usu ally without trigger zones, or may last hours. According to Day and Fukushima, 7 the majority of patients with TSs have paroxysmal lancinating facial pain in episodes that tend to last longer than classic trigeminal neuralgia and do not respond to carbamazepine. Some authors 8, 28, 32, 43 reported that trigeminal pain may be absent with tumors originating distally in the divisions, whereas it is more common in tumors arising from the ganglion. Other re ported symptoms are headaches, hearing impairment, hemifacial spasm, hemiparesis, ataxia, diplopia, signs of cerebellar involvement, increased ICP, and dysfunction of oculomotor, trochlear, and abducent nerves. 3, 27, 29, 32, 45 Al though rare, malignant tumors can present with involve ment in all 3 branches. 20, 22 Adequate preoperative neuroradiological evaluation is fundamental for establishing a correct diagnosis and treatment. Bone anatomy of the skull base is better evalu ated with CT scanning and plain radiographs, which gen erally reveal sharp amputation of the petrous apex, ante riormedial erosion of the petrous bone, and enlargement of the foramen ovale. 21, 30, 34 On CT scans, TSs usually ap pear iso to hyperintense compared with the surround ing brain, with clearly defined margins that strongly and uniformly enhance after intravenous contrast administra tion. 16, 33 Cystic changes may also be observed. An MR imaging study gives the best information concerning the localization and extent of the tumor in addition to reveal ing displacement of neighboring structures and involve ment of the cavernous sinus and vessels. On MR imaging, TSs appear hypointense in T1weighted and hyperintense on T2weighted images, with marked and homogeneous enhancement after intravenous Gd administration. 40 The differential diagnosis includes meningiomas, epidermoid cysts, metastasis, chondrosarcomas, chordomas, chon dromas, vestibular schwannomas, and maxillary sinus tumors.
Management strategy for TSs involves clinical obser vation followed by MR imaging followup for incidental tumors, surgical removal, and, alternatively, radiotherapy or radiosurgery. 2, 15, 19, 24, 25, 47 Complete or neartotal surgi cal removal can be achieved in > 70% of the patients by means of skull base approaches and microsurgical dissec tion. Involvement of the cavernous sinus is one cause of subtotal resection. In most cases, a clear plane of cleavage between the tumor capsule and the cavernous sinus struc tures can be found, allowing complete dissection and total resection. In the modern neurosurgical era, recurrence of TS is rare and the outcome is usually favorable; the most frequent symptom after surgery is trigeminal hypesthe sia, which is transient in most cases. Facial pain may per sist after surgery, but most patients report improvement or total relief during followup. Diplopia, CSF leakage, meningitis, and hydrocephalus have been also described as possible complications. Most new cranial nerve deficits present resolution within 4-6 months.
Although good results have been reported with ra diosurgery, this technique is reserved for small, nonre sectable, and residual tumors within the cavernous sinus. Longterm followup of patients treated with this method is still needed to evaluate the exact role of radiosurgery in the late control of these lesions. 1, [17] [18] [19] 31, 35, 36, 37, 44 It is evi dent, however, that no patient will ever be cured of this benign tumor with radiotherapy or radiosurgery. Several contemporary series have demonstrated no deaths or major surgical complications with radical re moval of TSs. 7, 11, 15, 41 In a classic series of 44 patients re ported by Dolenc, 11 total resection was achieved in 100% of the patients, including 5 who had undergone incom plete resection elsewhere and underwent another surgery to excise the remainder of the tumor. The authors recom mend an epidural approach to schwannomas originating in the fifth cranial nerve peripherally to the Gasserian ganglion and either an epiduraltransdural or an epidural transduraltranspetrous approach to lesions originating in the Gasserian ganglion or in the root of the fifth nerve.
Patients who had experienced preoperative atypical trigeminal pain reported a resolution of their symptoms after surgery. No additional treatment such as radiosur gery, other forms of irradiation, or chemotherapy was necessary.
Conclusions
Based on our experience and published data, we be lieve that the best treatment for TSs is complete microsur gical removal of the lesion, and that this treatment should be considered the gold standard therapeutic modality for the majority of cases when performed in selected, well established, skull base neurosurgical centers.
Finally, the modifications proposed in this article for the classification of Samii et al. 41 of tumor extension al lows a better choice of surgical approach and anticipation of surgical difficulties.
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Comment by Dr. Vinko Dolenc
Prior to the parasellar microanatomy studies and understanding of this tumor's complexity, treatment of TSs has been a difficult task. It is true that the diagnosis of these tumors was also very difficult prior to CT and MR imaging. Symptoms and signs in even large trigemi nal neurinomas might be and usually are minimal. In a considerable number of cases, the diagnosis of trigemi nal neurinoma is an incidental finding on imaging per formed for other reasons. The anatomical considerations are extremely important: Gasserian ganglion and V3 are exclusively outside of the parasellar space. Even V1 and V2 are not in the parasellar space but in its lateral wall, "encased" in delicate membranes from both sides. The roots of the fifth cranial nerve-its compact and its plexi form segments-are in the subarachnoid space as it is the smaller or larger part of the Gasserian ganglion.
On the basis of these anatomical data, it is clear that the surgical approaches should be tailored accordingly. With the extradural approach, most trigeminal neurino mas arising from V1, V2, V3, and peripheral region(s) of the Gasserian ganglion may be completely exenterated. When the lesion is located centrally from the Gasserian ganglion or in continuation from the middle to the pos terior cranial fossa, then the extraduralintraduraltrans petrous approach is the most preferred one. With this ap proach, all the tumors originating from the segment of the root of the fifth cranial nerve as well as from the Gas serian ganglion itself can be excised completely. Only ex ceptionally, the retrosigmoid approach might be chosen, and this is in cases in which the preoperative diagnosis is not 100% sure for trigeminal neurinoma.
For extracranial trigeminal neurinomas, splanch nocranial direct approaches might be practical, although when the tumor is also in the middle cranial fossa, it is the best way at least to combine the epidural transcranial approach with the splanchnocranial approach to achieve complete extirpation of the lesion. The 2 remaining prob lems associated with neurinomas of the region are as fol lows: 1) neurinomas as a part of neurofibromatosis, and 2) neurinomas originating in the parasellar space (cavernous sinus) from the sympathetic fibers accompanying the in ternal carotid artery. In these 2 entities, a radical excision is difficult-if possible at all-and most probably the best way is to combine the surgical treatment with radiosur gery.
In our practice, the presigmoid approach has never been used, because the necessity for it never existed. Re gardless of the size of the lesion, the intradural approach as it is described in this paper is not necessary for the extradural approach to be executed correctly. The orbit ozygomatic approach is also not necessary for this kind of lesion as well as splitting of the sylvian fissure. Surgery for trigeminal neurinomas is in fact the safest surgery for the region, and postoperative deficits should not exceed the preoperative ones; on the contrary, it should be less. There is one thing worth mentioning, and that is severe trigeminal pain, which may initiate the diagnosis of the disease; and when this occurs, it is the result of bleeding into the tumorous lesion, which suddenly increases the pressure against the surrounding structures. Such pain does subside in about a 1month interval if the patient does not accept surgical treatment before. And what is interesting is that diplopia, which might be the first symp tom (that is, it may occur earlier than sensory deficits), is usually (in > 50% of cases) due to displacement of the sixth cranial nerve and its being pushed against the hard and sharp edge of the bone inferolaterally. This cause of diplopia is much more frequent than diplopia due to ir ritation of the third and fourth cranial nerves.
